Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function
NCT ID: NCT04211571
Last Updated: 2023-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2020-04-23
2023-09-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration
NCT03448887
Comparison of the Clinical Performance of 3 THERANOVA 400 Dialyzer Prototypes With a High-Flux Dialyzer in Hemodialysis Mode
NCT02377570
Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer
NCT03211676
Clinical Performance Comparison of 2 THERANOVA 400 Dialyzer Prototypes in HD With High-Flux Dialyzers in HD and hv HDF Mode
NCT02377622
Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration
NCT03499691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MCO group
Hemodialysis using Theranova 400 dialyzer
Theranova 400 dialyzer
Hemodialysis using Theranova 400 dialyzer
High-flux group
Hemodialysis using high-flux dialyzer (Fx CorDiax 80; Fresenius Medical Care)
High-flux dialyzer
Hemodialysis using high-flux dialyzer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Theranova 400 dialyzer
Hemodialysis using Theranova 400 dialyzer
High-flux dialyzer
Hemodialysis using high-flux dialyzer
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years old and older
* Creatinine clearance of more than 2 ml/min
* Agreement to participate in the clinical study
* Vascular access by arteriovenous fistula/graft
Exclusion Criteria
* Severe volume overloading state
* Dialysis through permanent catheter
* Any hematologic malignancy or monoclonal gammopathy
* Any malignancy
* Active infectious disease
* HIV infection
* Patient enrolled to another study within 3 month from starting the present study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyungpook National University Chilgok Hospital
OTHER
Yeungnam University Hospital
OTHER
Ewha Womans University
OTHER
Baxter Healthcare Corporation
INDUSTRY
Kyungpook National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yong-Lim Kim
M.D., Ph.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kyungpook national university chilgok hospital
Daegu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kirsch AH, Lyko R, Nilsson LG, Beck W, Amdahl M, Lechner P, Schneider A, Wanner C, Rosenkranz AR, Krieter DH. Performance of hemodialysis with novel medium cut-off dialyzers. Nephrol Dial Transplant. 2017 Jan 1;32(1):165-172. doi: 10.1093/ndt/gfw310.
Lim JH, Seo YJ, Jeon Y, Jeon YH, Jung HY, Choi JY, Park SH, Kim CD, Kang SH, Ryu JH, Kang DH, Cho JH, Kim YL. Expanded Hemodialysis with Theranova Dialyzer and Residual Kidney Function in Patients Starting Long-Term Hemodialysis: A Randomized Controlled Trial. J Am Soc Nephrol. 2025 Mar 4;36(8):1614-1625. doi: 10.1681/ASN.0000000655.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KNU-Theranova-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.